Exercise Therapy for Management of Type 2 Diabetes Mellitus: Superior Efficacy of Activity Monitors over Pedometers

Table 2

Clinical background of patients in whom medications were not changed throughout the study.

	Activity monitor group ()	Pedometer group ()	value
Age (years)	65.8 ± 6.7	62.4 ± 9.9	0.58
Male	78.6%	71.4%	0.66
Height (m)	1.61 ± 0.08	1.63 ± 0.09	0.46
Weight (kg)	62.4 ± 12.7	68.3 ± 9.5	0.08
BMI	24.1 ± 4.0	25.9 ± 4.3	0.24
HbA1c (%)	6.6 ± 0.6	6.4 ± 0.9	0.27
Systolic BP (mmHg)	121.1 ± 10.8	121.6 ± 6.8	0.89
Diastolic BP (mmHg)	67.8 ± 8.1	73.5 ± 9.0	0.09
UA (mg/dL)	5.5 ± 1.6	5.6 ± 1.6	0.80
HDL cholesterol (mg/dL)	66.6 ± 18.7	60.3 ± 11.6	0.72
LDL cholesterol (mg/dL)	111.4 ± 34.9	103 ± 10.8	0.09
Triglycerides (mg/dL)	107.6 ± 59.7	127.1 ± 90.8	0.68

Values are mean ± SD.
BMI: body mass index; BP: blood pressure; UA: uric acid; HDL: high-density lipoprotein; LDL: low-density lipoprotein.